scispace - formally typeset
R

Robert V. Farese

Researcher at Harvard University

Publications -  484
Citations -  54181

Robert V. Farese is an academic researcher from Harvard University. The author has contributed to research in topics: Insulin & Protein kinase C. The author has an hindex of 115, co-authored 473 publications receiving 48754 citations. Previous affiliations of Robert V. Farese include University of South Florida & University at Buffalo.

Papers
More filters
Journal ArticleDOI

On the mechanism whereby ACTH and cyclic AMP increase adrenal polyphosphoinositides. Rapid stimulation of the synthesis of phosphatidic acid and derivatives of CDP - diacylglycerol.

TL;DR: The results suggest that the ACTH-induced increase in polyphosphoinositides is due to a rapid increase in phosphatidic acid and, subsequently, CDP-diacylglycerol andosphatidylinositol.
Journal ArticleDOI

PKC-ζ Mediates Insulin Effects on Glucose Transport in Cultured Preadipocyte-Derived Human Adipocytes

TL;DR: These findings provide convincing evidence that aPKCs and upstream activators, PI 3-kinase and PDK-1, play important roles in insulin-stimulated glucose transport in preadipocyte-derived human adipocytes.
Journal ArticleDOI

Progranulin: at the interface of neurodegenerative and metabolic diseases

TL;DR: Progranulin biology in both neurodegenerative and metabolic diseases is reviewed, highlighting the growth factor-like, trophic, and anti-inflammatory properties of progranulin as potential unifying themes in these seemingly divergent conditions.
Journal ArticleDOI

Polyphosphoinositides:stimulator of mitochondrial cholesterol side chain cleavage and possible identification as an adrenocorticotropin-induced, cycloheximide-sensitive, cytosolic, steroidogenic factor.

TL;DR: Findings from the laboratory suggest that polyphosphoinositides may function as a cycloheximide-sensitive mediator in the steroidogenic action of ACTH.
Journal ArticleDOI

Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1

TL;DR: The results suggest that the hyperphagia in Dgat1(-/-) mice is a secondary mechanism that compensates for the increased utilization of fuel substrates and increased energy expenditure in a murine model of obesity resistance.